| Literature DB >> 30026670 |
Yanling Wang1, Yu Gu1, Fei Huang1, Dezhao Liu1, Zheng Zhang1, Niman Zhou1, Jiani Liang1, Changyin Lu1, Dongdong Yuan1, Ziqing Hei1.
Abstract
Sepsis is a common complication of solid organ transplant procedures and, in particular, can affect the prognosis of orthotopic liver transplantation (OLT). This retrospective study determined the pre-, peri-, and postoperative risk factors for sepsis after OLT, using as reference the 2016 Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Pre-, peri-, and postoperative clinical data of the sepsis-positive (n = 85) and sepsis-negative (n = 41) groups were analyzed for potential risk factors of OLT-related sepsis. The sepsis-positive patients had a significantly higher rate of dialysis (49.4%), longer time under mechanical ventilation (1.5 d), higher hospitalization costs (0.41 million RMB), and worse survival rate (68.5%), compared with the sepsis-negative patients (4.8%, 1 d, 0.30 million RMB, and 73.1%, resp.). The multivariate logistic analysis identified the following as risk factors for OLT-related sepsis: preoperative Child-Pugh grade C (OR 10.43; 95% CI 2.081-52.292; P = 0.004), preoperative hypercalcemia (OR 6.372; 95% CI 1.693-23.98; P = 0.006), and perioperative acidosis (OR 6.364; 95% CI 1.196-33.869; P = 0.030). Patients with preoperative Child-Pugh grade C, preoperative hypercalcemia, or perioperative acidosis are at higher risk for developing sepsis after OLT. When any of these problems occur, timely sepsis management should be planned.Entities:
Mesh:
Year: 2018 PMID: 30026670 PMCID: PMC6031077 DOI: 10.1155/2018/8703172
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Figure 1Study population and exclusion criteria in the current retrospective study.
The major pathogens for sepsis after orthotopic liver transplantation (OLT).
| Pathogens | Percentage (%) |
|---|---|
| Gram-negative bacteria | 29 |
| | 10 |
| | 5 |
| | 3 |
| | 2 |
| | 6 |
| | 2 |
| | 1 |
| Fungi | 14 |
| | 5 |
| | 3 |
| | 2 |
| | 1 |
| Others | 3 |
Prognosis of patients with or without orthotopic liver transplantation- (OLT-) related sepsis (reported as n (%), unless otherwise noted).
| Sepsis-negative | Sepsis-positive |
| |
|---|---|---|---|
| Subjects, | 41 | 85 | — |
| Dialysis | 2 (4.8) | 42 (49.4) | <0.001 |
| Reintubation/tracheostomy | 3 (7.3) | 16 (18.8) | 0.334 |
| Fiber bronchoscope suction | 8 (19.5) | 10 (11.7) | 0.543 |
| Medicines after OLT | |||
| Alprostadil | 19 (46.3) | 21 (24.7) | 0.052 |
| Terlipressin | 6 (14.6) | 10 (11.8) | 0.880 |
| RhIL-11a | 17 (41.5) | 19 (22.4) | 0.071 |
| Duration of ICUb stay, d | 3 (2–5) | 3.5 (2–10) | 0.072 |
| Mechanical ventilation, d | 1 (1–1) | 1.5 (1–3) | 0.022 |
| Returning to ICU | 3 (7.3) | 14 (16.5) | 0.438 |
| Hospitalization after OLT, d | 35 (28–48) | 44 (38–63) | 0.066 |
| Hospitalization costs, 106 RMBc | 0.30 (0.24–0.34) | 0.41 (0.34–0.63) | <0.001 |
aRhIL-11: recombinant human interleukin 11; bICU: intensive care unit; cRMB: Chinese renminbi.
Figure 2Survival rate and sepsis.
Preoperative clinical characteristics of patients with or without orthotopic liver transplantation- (OLT-) related sepsis (normally distributed data) (reported as n (%) unless otherwise noted).
| Sepsis-negative | Sepsis-positive |
| |
|---|---|---|---|
| Age, y | 44.44 ± 8.63 | 49.08 ± 10.92 | 0.067 |
| Male/female | 41/0 | 69/16 | 0.044 |
| Portal hypertension | 21 (51.2) | 46 (54.1) | 0.555 |
| Hypertension | 0 | 8 (9.4) | 0.260 |
| Serum albumin, g/l | 32.69 ± 5.62 | 35.54 ± 6.08 | 0.155 |
| Smoking | 6 (14.6) | 13 (15.3) | 1.000 |
| Drinking | 8 (19.5) | 13 (15.3) | 0.886 |
| Diabetes | 10 (24.4) | 18 (21.2) | 0.813 |
| Etiology | |||
| Liver cirrhosis | 14 (34.1) | 27 (31.8) | 0.099 |
| Severe hepatitis | 6 (14.6) | 19 (22.4) | |
| Hepatic carcinoma | 17 (41.5) | 17 (20) | |
| Others | 3 (7.3) | 21 (24.7) | |
| Child-Pugh grade | |||
| A | 14 (34.1) | 8 (9.4) | 0.014 |
| B | 11 (26.8) | 21 (24.7) | |
| C | 16 (39.0) | 56 (65.9) | |
| MELDa score | |||
| <11 | 9 (22.0) | 35 (41.2) | 0.049 |
| 11–18 | 19 (46.3) | 24 (28.2) | |
| 19–24 | 5 (12.2) | 21 (24.7) | |
| ≥25 | 8 (19.5) | 5 (5.9) | |
| Serum potassium | |||
| Normal | 35 (85.4) | 61 (71.8) | 0.372 |
| Hypokalemia | 5 (12.2) | 21 (24.7) | |
| Hyperkalemia | 2 (4.8) | 3 (3.5) | |
| Serum sodium | |||
| Normal | 25 (60.9) | 56 (65.9) | 0.694 |
| Hyponatremia | 16 (39.0) | 29 (34.1) | |
| Serum calcium | |||
| Normal | 33 (80.5) | 43 (50.6) | 0.011 |
| Hypercalcemia | 8 (19.5) | 42 (49.4) | |
| Blood glucose | |||
| Normal | 22 (53.7) | 54 (63.5) | 0.461 |
| Hypoglycemia | 11 (26.8) | 13 (15.3) | |
| Hyperglycemia | 8 (19.5) | 18 (21.1) | |
| Pneumonia | 17 (41.5) | 27 (31.8) | 0.372 |
| Biliary tract infection | 6 (14.6) | 6 (7.1) | 0.491 |
| Other infection | 10 (24.4) | 13 (15.3) | 0.578 |
aMELD: model for end-stage liver disease.
Preoperative measurements of patients with or without orthotopic liver transplantation- (OLT-) related sepsis (abnormally distributed data).
| Sepsis-negative | Sepsis-positive |
| |
|---|---|---|---|
| Subjects, | 41 | 85 | — |
| White blood cell count, ×109/l | 10.13 (3.45–15.43) | 5.17 (2.84–10.37) | 0.061 |
| Prothrombin time, s | 21.80 (16.70–33.00) | 26.80 (15.90–34.70) | 0.754 |
| Activated partial thromboplastin time, s | 71.00 (46.00–76.00) | 59.00 (41.00–71.40) | 0.236 |
| Serum creatinine, | 80.00 (66.00–168.50) | 84.00 (66.50–105.50) | 0.406 |
| Blood urea nitrogen, mmol/l | 13.60 (4.53–31.56) | 6.20 (3.88–12.61) | 0.059 |
Perioperative characteristics of patients with or without orthotopic liver transplantation- (OLT-) related sepsis.
| Sepsis-negative | Sepsis-positive |
| |
|---|---|---|---|
| Cold ischemia, h | 6.00 (6.00–8.00) | 6.00 (5.25–6.75) | 0.217 |
| OLT, h | 6.92 (6.11–8.42) | 7.00 (6.07–8.33) | 0.829 |
| Anhepatic phase, min | 52.00 (46.00–60.50) | 52.00 (47.00–65.00) | 0.728 |
| Ulinastatin, million U | 0.60 (0.53–0.65) | 0.60 (0.3–0.63) | 0.082 |
| Albumin infusion, ml | 200 (150–300) | 250 (150–300) | 0.365 |
| Red blood cell transfusion, ml | 1675 (750–2800) | 2800 (1500–4400) | 0.010 |
| Plasma transfusion, l | 3.00 (2.35–4.00) | 3.40 (2.30–5.50) | 0.286 |
| Fresh frozen plasma transfusion, U | 39.00 (22.50–47.50) | 40.00 (30.00–50.00) | 0.485 |
| Fluid infusion, ml | 6375 (5690–7300) | 7700 (6253–10,120) | 0.049 |
| Bleeding volume, ml | 2500 (1000–3450) | 3000 (1800–6000) | 0.113 |
| Urine volume, ml | 1600 (1300–2125) | 1350 (763–2000) | 0.081 |
| Hypokalemia, | 5 (12.2) | 26 (30.6) | 0.068 |
| Acidosis, | 3 (7.3) | 27 (31.8) | 0.017 |
Postoperative clinical characteristics of patients with or without orthotopic liver transplantation- (OLT-) related sepsis (reported as n (%), unless otherwise noted).
| Sepsis-negative | Sepsis-positive |
| |
|---|---|---|---|
| Subjects, | 41 | 85 | — |
| Albumin infusion, ml | 1700 (600–2450) | 2100 (950–2900) | 0.357 |
| Pneumonia | 29 (70.7) | 53 (62.4) | 0.720 |
| Intestinal infection | 13 (31.7) | 18 (21.2) | 0.328 |
| Serum potassium | |||
| Normal | 29 (70.7) | 37 (43.5) | 0.060 |
| Hypokalemia | 11 (26.8) | 46 (54.1) | |
| Hyperkalemia | 2 (4.8) | 2 (2.3) | |
| Blood glucose | |||
| Normal | 8 (19.5) | 27 (31.8) | 0.231 |
| Abnormala | 33 (80.5) | 58 (68.2) |
aAll of the abnormal blood glucose patients were in hyperglycemia, except one patient was in hypoglycemia in the sepsis-positive group.
Univariate logistic analysis for the incidence of sepsis after orthotopic liver transplantation (OLT) (reported as n (%), unless otherwise noted).
| B | SE | Wals | Sig. | Exp (B) 95% CI | |
|---|---|---|---|---|---|
| Preoperative | |||||
| Child-Pugh grade | |||||
| A | — | — | 7.734 | 0.021 | — |
| B | 1.207 | 0.729 | 2.743 | 0.098 | 3.343 (0.802–13.942) |
| C | 1.841 | 0.663 | 7.705 | 0.006 | 6.3 (1.718–23.108) |
| MELDa score | |||||
| <11 | — | — | 7.353 | 0.061 | — |
| 11–18 | −1.076 | 0.602 | 3.198 | 0.074 | 0.341 (0.105–1.109) |
| 19–24 | 0.167 | 0.789 | 0.045 | 0.832 | 1.182 (0.252–5.547) |
| ≥25 | 1.81 | 0.863 | 4.395 | 0.116 | 0.164 (0.103–1.889) |
| Hypercalcemia | 1.397 | 0.568 | 6.043 | 0.014 | 4.044 (1.327–12.323) |
| Perioperative | |||||
| RBCb infusion (>2250 ml) | 1.112 | 0.521 | 4.558 | 0.033 | 3.04 (1.095–8.436) |
| Fluid infusion | 1.647 | 1.107 | 3.014 | 0.812 | 5.689 (1.283–35.687) |
| Acidosis | 1.735 | 0.793 | 4.789 | 0.029 | 5.667 (1.18–26.793) |
aMELD: model for end-stage liver disease; bRBC: red blood cell.
Multivariate logistic analysis for the incidence of sepsis after orthotopic liver transplantation (OLT).
| B | SE | Wals | Sig. | Exp (B) 95% CI | ||
|---|---|---|---|---|---|---|
| Preoperative Child-Pugh grade | ||||||
| A | — | — | 8.152 | 0.017 | — | |
| B | 1.652 | 0.891 | 3.441 | 0.064 | 5.22 (0.911–29.915) | |
| C | 2.345 | 0.823 | 8.126 | 0.004 | 10.43 (2.081–52.292) | |
| Hypercalcemia | 1.852 | 0.676 | 7.5 | 0.006 | 6.372 (1.693–23.98) | |
| Perioperative acidosis | 1.851 | 0.853 | 4.706 | 0.03 | 6.364 (1.196–33.869) |